SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-052972
Filing Date
2019-02-27
Accepted
2019-02-27 08:40:32
Documents
3
Effectiveness Date
2019-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 d715362ds8.htm S-8 48514
2 EX-5.1 d715362dex51.htm EX-5.1 4701
3 EX-23.2 d715362dex232.htm EX-23.2 1552
  Complete submission text file 0001193125-19-052972.txt   55786
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-229900 | Film No.: 19635922
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences